are contributed equally to this work.Abbreviations: Abcc6, ATP binding cassette subfamily c member 6; BB-FCF, brilliant blue-FCF; Cx30, connexin30; Cx30.3, connexin30.3; Cx37, connexin37; Entpd2, ectonucleoside triphosphate diphosphohydrolase 2; Entpd3, ectonucleoside triphosphate diphosphohydrolase 3; FBS, fetal bovine serum; FSS, fluid shear stress; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; MO, translation blocking morpholino; Nt5e, ecto-5′-nucleotidase; Panx1, pannexin-1; PC1, polycystin-1; PC2, polycystin-2; PKD, polycystic kidney disease; Pkd1, polycystic kidney disease 1; Pkd2, polycystic kidney disease 2; Ptgs2, prostaglandin-endoperoxide synthase 2.
AbstractTubular ATP release is regulated by mechanosensation of fluid shear stress (FSS).Polycystin-1/polycystin-2 (PC1/PC2) functions as a mechanosensory complex in the kidney. Extracellular ATP is implicated in polycystic kidney disease (PKD), where PC1/PC2 is dysfunctional. This study aims to provide new insights into the ATP signaling under physiological conditions and PKD. Microfluidics, pharmacologic inhibition, and loss-of-function approaches were combined to assess the ATP release in mouse distal convoluted tubule 15 (mDCT15) cells. Kidney-specific Pkd1 knockout mice (iKsp-Pkd1 −/− ) and zebrafish pkd2 morphants (pkd2-MO) were as models for PKD. FSS-exposed mDCT15 cells displayed increased ATP release. Pannexin-1 inhibition and knockout decreased FSS-modulated ATP release. In iKsp-Pkd1 −/− mice, elevated renal pannexin-1 mRNA expression and urinary ATP were observed. In Pkd1 −/− mDCT15 cells, elevated ATP release was observed upon the FSS mechanosensation. In these cells, increased pannexin-1 mRNA expression was observed.Importantly, pannexin-1 inhibition in pkd2-MO decreased the renal cyst growth. Our results demonstrate that pannexin-1 channels mediate ATP release into the tubular lumen due to pro-urinary flow. We present pannexin-1 as novel therapeutic target to prevent the renal cyst growth in PKD.
K E Y W O R D SATP, fluid shear stress, pannexin-1, polycystin-1, purinergic signaling | 6383 VERSCHUREN Et al.